Dianthus Therapeutics, Inc.DNTHNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-10.23%
↑ 40% above average
Average (34q)
-17.01%
Historical baseline
Range
High:88.70%
Low:-334.33%
Volatility
-2486.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -10.23% |
| Q2 2025 | -7.32% |
| Q1 2025 | -1.23% |
| Q4 2024 | -9.46% |
| Q3 2024 | -45.10% |
| Q2 2024 | 5.56% |
| Q1 2024 | 76.82% |
| Q4 2023 | 38.34% |
| Q3 2023 | -334.33% |
| Q2 2023 | 88.70% |
| Q1 2023 | -188.39% |
| Q4 2022 | -27.14% |
| Q3 2022 | 55.32% |
| Q2 2022 | 24.74% |
| Q1 2022 | -18.94% |
| Q4 2021 | -10.32% |
| Q3 2021 | 5.63% |
| Q2 2021 | 12.44% |
| Q1 2021 | 3.84% |
| Q4 2020 | -2.22% |
| Q3 2020 | 23.99% |
| Q2 2020 | 5.17% |
| Q1 2020 | 14.60% |
| Q4 2019 | -10.06% |
| Q3 2019 | -11.90% |
| Q2 2019 | -8.87% |
| Q1 2019 | 11.69% |
| Q4 2018 | -3.47% |
| Q3 2018 | -21.60% |
| Q2 2018 | -26.53% |
| Q1 2018 | -35.03% |
| Q4 2017 | -19.49% |
| Q3 2017 | 56.04% |
| Q2 2017 | -226.61% |
| Q1 2017 | 0.00% |